Study for Technology-Based Depression Referral in Cancer Survivors

This study is testing a new text-based approach called "Technology-Enabled Tailored Referral" to help cancer survivors with depression connect with care. Many cancer survivors experience depression, and this study aims to make it easier for them to get the help they need. We want to see if this text-based platform is practical to use and if people like it. You might be able to join if you are over 18, have a cancer diagnosis, have an upcoming oncology appointment, speak English, own a cellphone with text ability, and have elevated depressive symptoms. The study's current status is unclear, and it plans to enroll 60 participants.

Study design
This interventional study aims to enroll 60 participants. It will compare a technology-enabled approach to usual care.
What's involved
Not specified in the trial record.
Compensation
Not stated in the trial record.
Follow-up
Feasibility and acceptability will be measured at 6 weeks.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT07091968

Feasibility of a Technology-Based Intervention for Depression Referral Uptake in Cancer Survivors

Recruiting
NAAges 18+InterventionalSupportive care
Medical University of South Carolina
~60 participants
Updated 2026-07-13 on ClinicalTrials.gov
What's tested:Technology-Enabled Tailored Referral

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Feasibility and Acceptability
Measured over 6 weeks
Cancer
Depression
1 sites across 1 states
South Carolina1
  • Katherine Sterba, PhD · PRINCIPAL_INVESTIGATOR · Medical University of South Carolina
Lily P Research Assistant/Coordinator, MPH
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

age \> 18 years
diagnosis of cancer
upcoming appointment in an HCC or HCN oncology clinic within 14 days
English proficiency
ownership of a cellphone with SMS text capability.
elevated depressive symptoms at screening (as measured by \> 3 on the PHQ-2)

Exclusion

cognitive impairment as evaluated by attending physician
currently receiving counseling for depression
  • Feasibility and Acceptability6 weeks

    The co-primary outcomes are acceptability and feasibility of the technology-enabled referral intervention. Acceptability will be measured using the System Usability Scale (SUS) at 6 weeks, with a score ≥80 indicating high acceptability. Feasibility will be assessed by determining whether key components of the intervention were successfully delivered and engaged with over the course of the 4 week intervention, including: (1) initiation of text-based contact, (2) delivery of tailored messages, and (3) access of the automated referral link by the participant. Additionally, participant engagement will be evaluated by tracking whether they opened the initial message, viewed the embedded video, and read the tailored text messages. These outcomes will be summarized using a Bayesian beta-binomial approach to determine go/no-go decision thresholds for future scale-up.